Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence (original) (raw)
- Xianghong Zou1,
- Dipankar Ray1,
- Aileen Aziyu1,
- Konstantin Christov2,
- Alexander D. Boiko1,3,
- Andrei V. Gudkov1,3, and
- Hiroaki Kiyokawa1,4
- Departments of 1Molecular Genetics and 2Surgical Oncology, University of Illinois College of Medicine, Chicago, Illinois 60607, USA; 3Department of Molecular Biology, Lerner Research Institute, the Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Abstract
A large number of human cancers display alterations in the_Ink4a/cyclin D/Cdk4_ genetic pathway, suggesting that activation of Cdk4 plays an important role in oncogenesis. Here we report that_Cdk4-null mouse embryonic fibroblasts are resistant to transformation in response to Ras activation with dominant-negative (DN) p53 expression or in the Ink4a/Arf_-null background, judged by foci formation, anchorage-independent growth, and tumorigenesis in athymic mice. Cdk4_-null fibroblasts proliferate at normal rates during early passages. Whereas_Cdk4 +/+ Ink4a/Arf −/− cells are immortal in culture,Cdk4 −/− Ink4a/Arf −/− cells undergo senescence during continuous culture, as do wild-type cells. Activated Ras also induces premature senescence in_Cdk4 −/− Ink4a/Arf −/− cells and_Cdk4 −/− cells with DNp53 expression. Thus, Cdk4 deficiency causes senescence in a unique Arf/p53-independent manner, which accounts for the loss of transformation potential._Cdk4_-null cells express high levels of p21Cip1/Waf1with increased protein stability. Suppression of p21Cip1/Waf1by small interfering RNA (siRNA), as well as expression of HPV-E7 oncoprotein, restores immortalization and Ras-mediated transformation in Cdk4 −/− Ink4a/Arf −/− cells and Cdk4 −/− cells with DNp53 expression. Therefore, Cdk4 is essential for immortalization, and suppression of Cdk4 could be a prospective strategy to recruit cells with inactive Arf/p53 pathway to senescence.
Footnotes
↵4 Corresponding author.
E-MAIL kiyokawa{at}uic.edu; FAX (312) 413-2028.
Supplemental material is available at http://www.genesdev.org.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1033002.
- Received August 27, 2002.
- Accepted September 30, 2002.
Cold Spring Harbor Laboratory Press